Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy

This study is testing whether radiation delivered with MRI guidance using a so-called MR-linac in distal rectal cancer can result in a high rate of organ preservation. Patients will receive radiotherapy together with standard chemotherapy.

NCT Number	NCT07337876
Lead Sponsor	University Hospital Tuebingen
Conditions	Rectal Cancer
Enrollment	100 participants
Start Date	2026-01-07
Primary Completion	2029-01 (estimated)
Study Completion	2029-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-17